Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis

Tatsushi Yoshida, Masako Konishi, Mano Horinaka, +6

Biochemical and Biophysical Research Communications

MedicineColon Cancer CellsApoptosisCell DeathAnti-cancer Agent +4

Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells

Hiroya Taniguchi, Tatsushi Yoshida, Mano Horinaka, +7

Cancer Research

The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin?

Wageh M. Awara, Alaa E. El‐Sisi, Magda El‐Sayed El‐Sayad, +1

Pharmacological Research

Breast OncologyOncologyMedicineAnti-tumour ActivityPathology +8

Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice

Yusuf A. Haggag, Mohammed Osman, Sanaa A. El‐Gizawy, +4

Biomedicine & Pharmacotherapy

NanomedicinePolymer-drug ConjugateMedicinePolymeric Nano-encapsulationPharmaceutical Nanotechnology +5

Anti-Gout Agent Allopurinol Exerts Cytotoxicity to Human Hormone-Refractory Prostate Cancer Cells in Combination with Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand

Takashi Yasuda, Tatsushi Yoshida, Ahmed E. Goda, +7

Molecular Cancer Research

Chitosan-encapsulated niosomes for enhanced oral delivery of atorvastatin

Noha D. Fayed, Ahmed E. Goda, Ebtesam A. Essa, +1

Journal of Drug Delivery Science and Technology

Cell-based Drug DeliveryNanomedicineEngineeringChitosan-encapsulated NiosomesNano-drug Delivery +3

Targeting the Glyoxalase Pathway Enhances TRAIL Efficacy in Cancer Cells by Downregulating the Expression of Antiapoptotic Molecules

Hiroya Taniguchi, Mano Horinaka, Tatsushi Yoshida, +5

Molecular Cancer Therapeutics

Antiapoptotic MoleculesApoptosisCell DeathCancer BiologyTumor Biology +14

Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole

Ahmed E. Goda, Tomonori Yoshida, Mano Horinaka, +4

Oncogene

Oncogenic AgentMedicineTrail Tumoricidal ActivityPharmacologyDifferent Origin +7

Molecular mechanisms of the antitumor activity of SB225002: A novel microtubule inhibitor

Ahmed E. Goda, Makoto Koyama, Yoshihiro Sowa, +4

Biochemical Pharmacology

Molecular PharmacologyInhibitory ActivityAntitumor ActivityNovel Microtubule InhibitorMedicine +10

Histone Deacetylase Inhibitors and 15-Deoxy-Δ12,14-Prostaglandin J2 Synergistically Induce Apoptosis

Makoto Koyama, Yasuyuki Izutani, Ahmed E. Goda, +9

Clinical Cancer Research